2014 Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Chalandon Y Journal Haematologica
2014 Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Onida F Journal Haematologica
2014 Improved PFS after autologous stem cell transplantation does not translate into better Quality of Life in CLL: lessons from the randomized EBMT-Intergroup study. Group Chronic Malignancies Working Party (CMWP) 1st listed author de Wreede LC Journal Am J Hematol.
2014 Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Hussein AA Journal Biol Blood Marrow Transplant.
2014 Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2014 Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Group Chronic Malignancies Working Party (CMWP) 1st listed author Morris C Journal Transfusion
2014 Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Group Chronic Malignancies Working Party (CMWP) 1st listed author Auner HW Journal Bone Marrow Transplant.
2014 Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Lussana F Journal Haematologica
2013 Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Leukemia
2013 Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gahrton G Journal Blood
2013 Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data Group Chronic Malignancies Working Party (CMWP) 1st listed author Brand R Journal PLos One
2013 Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Auner HW Journal Bone Marrow Transplant.